SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Mizuho Downgrades National Health Investors to Neutral, Lowers Price Target of $55

Mizuho analyst Omotayo Okusanya downgrades National Health Investors (NYSE:NHI) from Buy to Neutral and lowers the price target from $60 to $55.

Benzinga · 05/22/2020 09:51

Mizuho analyst Omotayo Okusanya downgrades National Health Investors (NYSE:NHI) from Buy to Neutral and lowers the price target from $60 to $55.